GENTA INCORPORATED /DE/
4, 1997-06-10
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4, 1997-06-10
Next: I STAT CORPORATION /DE/, SC 13G/A, 1997-06-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   Aries, Domestic Fund, LP
   787 Seventh Avenue
   44th Floor
   New York, NY  10019
2. Issuer Name and Ticker or Trading Symbol
   Genta Incorporated
   GNTAC
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   05/97
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   (X) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
12% Senior Secured Con|$50.00  |5/29/|C   | |$227,500   |D  |1/28/|fully|Series D Con|4,550  |$227,50|$822,500(1) |D  |            |
vertible Bridge Notes |        |97   |    | |           |   |97   | paid|vertible Pre|       |0      |            |   |            |
                      |        |     |    | |           |   |     |     |ferred Stock|       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible P|$3.00   |     |C   | |4,550      |A  |5/29/|N/A  |Common Stock|151,667|$50.00 |21,000 (2)  |D  |            |
referred Stock, par va|        |     |    | |           |   |97   |     |            |       |       |            |   |            |
lue $.001 per share   |        |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1) Does not include the interest on the 12% Senior Secured  Convertible  Bridge
Notes  ("Bridge  Notes"),  including  the  interest on the $227,500 of converted
Bridge Notes  principal,  which has accrued at a rate of 12% per annum since the
Bridge Notes' issuance on January 28, 1997 (the "Note Interest").
(2) Does not include shares of Series D Preferred Stock issuable upon conversion
of the Note Interest.

SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- -----------------------------
Lindsay A. Rosenwald, M.D., President
Paramount Capital Asset Management, General Partner
Aries Domestic Fund, L.P.

DATE
06/10/97

<PAGE>

                                  Attachment A

         Reporting Person:          The Aries Domestic Fund, L.P.
         Issuer:                    Genta Incorporated (GNTAC)
         Statement For:             May/1997

     Paramount Capital Asset Management, Inc. ("Paramount"), the General Partner
of the  Aries  Domestic  Fund,  L.P.  (the  "Partnership"),  also  serves as the
Investment  Manager to The Aries Trust (the  "Trust"),  a Cayman  Islands trust,
which also owns  securities of the Issuer.  Lindsay A.  Rosenwald,  M.D., is the
sole shareholder of Paramount.  Paramount and Dr. Rosenwald disclaim  beneficial
ownership of the securities held by the Partnership and the Trust, except to the
extent of their pecuniary interest therein.




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission